Advertisement

Topics

Investment Analysts' Upgrades for November, 8th (CAH, CYBR, FHN,...

09:15 EST 9 Nov 2017 | Topix

According to Zacks, "Over the last year, Cardinal Health has underperformed the broader industry with respect to price. Increasing generic pricing pressure is a major headwind.

Original Article: Investment Analysts' Upgrades for November, 8th (CAH, CYBR, FHN,...

NEXT ARTICLE

More From BioPortfolio on "Investment Analysts' Upgrades for November, 8th (CAH, CYBR, FHN,..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...